Bluechiip Ltd
ASX:BCT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Bluechiip Ltd
Bluechiip Ltd. engages in the development of information technology-based temperature and identification tracking solution for biosamples in the health and life sciences industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-09. The firm offers technical capabilities over handwritten and printed labels, barcodes and radio frequency identification (RFID) technologies. Its products include Bluechiip Enabled Vial Range, Bluechiip Universal CryoBox, Bluechiip CryoTag Range, Bluechiip BoxTracker, Bluechiip MultiVial Reader, Bluechiip Handheld Reader, Stream 5 Sample Management Software, Bluechiip Ready CryoCassettes, and Bluechiip Ready Towers and Frames. Its intellectual property (IP) portfolio includes 24 granted patents in seven families, including the core micro electro mechanical system (MEMS) memory device and sample storage. The company also monitors systems that include sample level identification (ID) and temperature tracking.
Bluechiip Ltd. engages in the development of information technology-based temperature and identification tracking solution for biosamples in the health and life sciences industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-09. The firm offers technical capabilities over handwritten and printed labels, barcodes and radio frequency identification (RFID) technologies. Its products include Bluechiip Enabled Vial Range, Bluechiip Universal CryoBox, Bluechiip CryoTag Range, Bluechiip BoxTracker, Bluechiip MultiVial Reader, Bluechiip Handheld Reader, Stream 5 Sample Management Software, Bluechiip Ready CryoCassettes, and Bluechiip Ready Towers and Frames. Its intellectual property (IP) portfolio includes 24 granted patents in seven families, including the core micro electro mechanical system (MEMS) memory device and sample storage. The company also monitors systems that include sample level identification (ID) and temperature tracking.
